Intrinsic Value of S&P & Nasdaq Contact Us

uniQure N.V. QURE NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • NL • USD

SharesGrow Score
38/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$35.89
+110%

uniQure N.V. (QURE) — Analyst outlook / Analyst consensus target is. Based on 36 analyst ratings, the consensus is bullish — 1 Strong Buy, 29 Buy, 6 Hold.

The consensus price target is $35.89 (low: $11.00, high: $70.00), representing an upside of 110% from the current price $17.09.

Analysts estimate Earnings Per Share (EPS) of $-4.08 and revenue of $0.04B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-4.92 vs est $-4.08 (missed -20.5%). 2025: actual $-3.46 vs est $-3.87 (beat +10.7%). Analyst accuracy: 86%.

QURE Stock — 12-Month Price Forecast

$35.89
▲ +110.01% Upside
Average Price Target
Based on 36 Wall Street analysts offering 12-month price targets for uniQure N.V., the average price target is $35.89, with a high forecast of $70.00, and a low forecast of $11.00.
The average price target represents a +110.01% change from the last price of $17.09.
Highest Price Target
$70.00
Average Price Target
$35.89
Lowest Price Target
$11.00

QURE Analyst Ratings

Buy
36
Ratings
30 Buy
6 Hold
Based on 36 analysts giving stock ratings to uniQure N.V. in the past 3 months
Rating breakdown
Strong Buy
1 3%
Buy
29 81%
Hold
6 17%
83%
Buy
30 analysts
17%
Hold
6 analysts
0%
Sell
0 analysts

EPS Estimates — QURE

86%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$4.92 vs Est –$4.08 ▼ 17.0% off
2025 Actual –$3.46 vs Est –$3.87 ▲ 11.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — QURE

76%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024 Actual $0.027B vs Est $0.039B ▼ 45.4% off
2025 Actual $0.016B vs Est $0.016B ▲ 2.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message